Notice of extraordinary general meeting
Filed with HKEX · Stock code 2335 · · 4 pages · English
Summary by 6ix AI
Shaanxi Micot Pharmaceutical Technology Co., Ltd. has issued a notice for an extraordinary general meeting to be held in Xi’an, Shaanxi Province. The meeting aims to consider a special resolution regarding the granting of a general mandate to the Board for repurchasing H Shares. The resolution includes provisions for the Board to manage the repurchase process and comply with relevant laws and regulations. Shareholders are entitled to appoint proxies to vote at the meeting, and specific registration procedures are outlined for attendance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shaanxi Micot Pharmaceutical Technology Co., Ltd. on 6ix
Earlier from Shaanxi Micot Pharmaceutical Technology
- Proposed general mandate to repurchase h shares and notice of extraordinary general meeting
- Proposed adoption of the h share incentive scheme and proposed general mandate to repurchase h shares
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Notification letter to non-registered shareholders and reply form
- 2026 Interim report
Later from Shaanxi Micot Pharmaceutical Technology
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
- Voluntary announcement - receipt of the first instalment of project funding under a national major science and technology project and obtaining ethics approval from the lead institution for the phase III clinical trial of MT200605
- Announcement in relation to the postponement of the EGM and change of book closure period
Follow Shaanxi Micot Pharmaceutical Technology into a list and get an email when it puts out news.
Follow Shaanxi Micot Pharmaceutical Technology